Literature DB >> 14582490

Lack of correlation between SREBF1 genotype and hyperlipidemia in individuals treated with highly active antiretroviral therapy.

Aiming Yang, Martin S King, Lixin Han, Jeffrey D Isaacson, Toby Mueller, David R Grimm, C Brun Scott, David A Katz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14582490     DOI： 10.1097/00002030-200309260-00024

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  3 in total

1.  Antiretroviral treatment-induced dyslipidemia in HIV-infected patients is influenced by the APOC3-related rs10892151 polymorphism.

Authors:  Gerard Aragonès; Carlos Alonso-Villaverde; Pedro Pardo-Reche; Anna Rull; Raúl Beltrán-Debón; Esther Rodríguez-Gallego; Laura Fernández-Sender; Jordi Camps; Jorge Joven
Journal:  BMC Med Genet       Date:  2011-09-22       Impact factor: 2.103

Review 2.  Antiretroviral therapy and dyslipidaemia: unlocking the code.

Authors:  Patrick W G Mallon
Journal:  PLoS Med       Date:  2006-01-24       Impact factor: 11.069

3.  Hypercholesterolemia is associated with the apolipoprotein C-III (APOC3) genotype in children receiving HAART: an eight-year retrospective study.

Authors:  Carlos A Rocco; Debora Mecikovsky; Paula Aulicino; Rosa Bologna; Luisa Sen; Andrea Mangano
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.